Consonance Capital Management LP Nkarta, Inc. Transaction History

Consonance Capital Management LP

  • $7.28 Million
  • Q3 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$26.67 - $38.76 $11.7 Million - $17 Million
-439,876 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$23.94 - $36.68 $3.12 Million - $4.78 Million
-130,379 Reduced 22.86%
439,876 $13.9 Million
Q1 2021

May 17, 2021
BUY
$31.33 - $59.61 $17.9 Million - $34 Million
570,255 New
570,255 $18.8 Million

Others Institutions Holding NKTX

# of Institutions
129
Shares Held
66.5M
Call Options Held
173K
Put Options Held
20K
View Full List

About Nkarta, Inc.

NKTX Quotes by TradingView
  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $140M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track Consonance Capital Management LP Portfolio

Follow Consonance Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Consonance Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Consonance Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email